The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Fri, 23rd Jan 2015 13:36

Director Dealings Summary - Week Ended January 23        
Company Name Position Buy or Sell Number of Shares Resulting Holding *Note
1PM Ron Russell Non-Executive Director Buy 40,907 7.3 million After posting positive results
Aberdeen Asset Management Richard Mully Non-Executive Director Buy 15,000 30,000  
Amati VCT Paul Jourdan Manager Buy 34,698 282,506  
Bankers Investment Trust David Wild Non-Executive Director Buy 8,403 12,803  
BlueRock Diamonds John Kilham CTO Buy 100,000 250,000  
British Land Co Charles Maudsley Director Sold 50,000 Undisclosed  
Cloudbuy Lyn Duncan CEO Buy 20,000 21.1 million 2 weeks after signing new website deal
Enteq Upstream David Steel CFO Buy 12,659 81,240 3 days after profit warning
e-Therapeutics Steve Medlicott  CFO Buy 150,000 250,000  
Flowgroup Nigel Canham CFO Buy 68,400 68,400 First purchase
Fulcrum Utility Services Stephen Gutteridge Non-Executive Director Buy 125,000 529,166 Week after deciding to take its operational delivery in-house
Games Workshop Elaine O'Donnell Non-Executive Director Buy 1,500 1,500 First purchase
Hilton Food Robert Watson CEO Sold 90,000 2.9 million 11 days after posting positive results
Judges Scientific Alex Hambro Chairman Sold 15,000 77,500 Same day as company bought Armfield Ltd for GBP8.3 million
Kingfisher Véronique Laury CEO Buy 100,000 Undisclosed  
Mithril Capital Rodger Sargent Non-Executive Director Buy 675,000 5.4 million  
Lamprell John Macdonald Senior Manager Buy 19,185 51,185 1 week after profit warning
Leed Resources Charles Zorab Non-Executive Director Buy 3.3 million 3.3 million 2 weeks after company agreed to invest in limestone miner
Lekoil Gregory Eckersley Non-Executive Director Buy 45,000 2.8 million Same day as project in Nigeria declared "robust"
London Capital Group Charles-Henri Sabet Chairman Buy 250,000 1.7 million Day after loan note conversions announced
Proton Power Thomas Melczer Business Development Director Sold 250,000 250,000 2 days after reporting a loss
REA Holdings Irene Chia Non-Executive Director Buy 1,000 Undisclosed  
Renew Holdings Brian May CEO Sold 350,000 494,193 Sold from his wife's shareholding
Rosslyn Data Tech Hugh Cox Director Buy 38,838 9.5 million  Same day as company posted a loss
Shanta Gold Luke Leslie Non-Executive Director Sold 3.3 million nil Sold  entire stake day after positive Q4 update
             
*Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event.
When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director
             
Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam    
             
Copyright 2015 Alliance News Limited. All Rights Reserved.        

More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
10 Jun 2019 13:33

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.